Latest Breaking News On - ஃபைசர் உயிர் மருந்துகள் - Page 1 : comparemela.com

Operator Good day, everyone, and welcome to Pfizer s second-quarter 2021 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, senior vice president and chief investment relations officer. Please go ahead, sir. Senior Vice President and Chief Investment Relations Officer Thank you, Sylvia. Good morning. It s my pleasure to be welcoming you to Pfizer s second-quarter earnings call for the first time as the head of investor relations at Pfizer. I m joined today by Dr. Albert Bourla, our chairman and CEO; Frank D Amelio, our CFO; Mikael Dolsten, president of worldwide research and development and medical; Angela Hwang, group president, Pfizer Biopharmaceuticals Group; John Young, our chief business officer; and Doug Lankler, general counsel. We ll begin the call with remarks by Albert, followed by a pipeline update from Mikael, and Frank will then give you his thoughts on the numbers and our updated guidance b

United statesBoston universityUnited kingdomFrank damelioDaniel busbyAndrew baumAlbert bourlaKerry holford berenbergChris stevoCarter gouldAngela hwangDoug lanklerAndrew baum citiKerry holfordGeoff meachamCarter gould barclays